In addition to changes to L-glutamic acid and aspartate, the metabolic shifts observed in SARS-CoV-2 infected ACE2-A549 cells reflect similar changes observed in COVID-19 positive patient serum samples [10,23,27,38–43]. This evidence concerns the gene ACE2 and COVID-19.